54741_Image_jpeg.jpg
Daxor to Present at the 2020 MicroCap Rodeo Best Ideas Bowl
12 oct. 2020 08h30 HE | Daxor Corporation
NEW YORK, NY, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...
54741_Image_jpeg.jpg
Daxor to Present at The MicroCap Conference on April 9th and 10th in New York City at the Essex House
05 avr. 2018 09h00 HE | Daxor Corporation
New York, NY, April 05, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announces it will present at...
AIMLogo.jpg
Hemispherx Biopharma Regains Compliance with NYSE MKT Continued Listing Standards
19 sept. 2016 08h30 HE | Hemispherx Biopharma, Inc.
PHILADELPHIA, Sept. 19, 2016 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) (the “Company”), announced today that, based on a notice received on September 15, 2016 from the New York Stock...
AIMLogo.jpg
Hemispherx Biopharma Announces Financial Results for the Nine Months Ended September 30, 2014
10 nov. 2014 08h30 HE | AIM ImmunoTech Inc.
PHILADELPHIA, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE:HEB) announced its financial results for the three and nine months ended September 30, 2014. The net loss (including non-cash...
Can-Fite BioPharma Announces Clinical and Corporate Developments for Near-Term Events
22 oct. 2013 15h10 HE | Can-Fite BioPharma
PETACH TIKVA, ISRAEL--(Marketwired - Oct 22, 2013) - Can-Fite BioPharma (TASE: CFBI), (OTCQB: CANFY), a biotechnology company with a pipeline of proprietary small molecule drugs that address...